CI
Cigna Corporation · Healthcare · Medical - Healthcare Plans
Momentum-inputs (vergelijkbare managers):
breedte van houders +8.7% ·
aandelenstroom +2.1% ·
netto nieuwe posities +8.0%
· formule
Brede accumulatie: stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 177 | 0 | 197.60M | $54.50B | +4 | −5 |
| Q1 2026 | 181 | +2 | 199.25M | $53.08B | +3 | −2 |
| Q4 2025 | 178 | +1 | 211.33M | $58.16B | +2 | n/a |
| Q3 2025 | 27 | 0 | 123.40M | $35.56B | n/a | −1 |
| Q2 2025 | 25 | +2 | 110.22M | $36.42B | +2 | n/a |
| Q1 2025 | 20 | +1 | 48.70M | $16.02B | +1 | n/a |
| Q4 2024 | 19 | -1 | 48.42M | $13.37B | n/a | −1 |
| Q3 2024 | 19 | -1 | 37.77M | $13.08B | n/a | −1 |
| Q2 2024 | 20 | n/a | 38.82M | $12.83B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 25.73M | n/a | $8.50B | 0.1% | n/c | 1 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (passief) | 22.33M | n/a | $7.38B | 0.1% | n/c | 1 | SEC ↗ ×22 |
| 3 | State Street Global Advisors ✦ (passief) | 12.26M | -1.7% | $4.05B | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 11.17M | n/a | $3.69B | 0.2% | n/c | 1 | SEC ↗ ×6 |
| 5 | T. Rowe Price ✦ | 10.29M | -14.6% | $3.40B | 0.4% | ▼ Trim | 5 | SEC ↗ ×2 |
| 6 | Dodge & Cox ✦ | 8.95M | +0.7% | $2.96B | 1.7% | ▲ Add | 5 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passief) | 5.96M | -1.2% | $1.96B | 0.1% | ▼ Trim | 5 | SEC ↗ ×2 |
| 8 | Norges Bank ✦ (passief) | 3.36M | +12.1% | $1.11B | 0.1% | ▲ Add | 5 | SEC ↗ |
| 9 | Arrowstreet Capital ✦ | 2.51M | +24.4% | $829.34M | 0.6% | ▲ Add | 5 | SEC ↗ |
| 10 | Capital World Investors ✦ | 1.29M | +2.1% | $427.00M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 1.24M | +1461.0% | $408.68M | 0.4% | ▲ Add | 5 | SEC ↗ ×2 |
| 12 | AQR Capital Management ✦ | 1.14M | -1.2% | $372.61M | 0.3% | ▼ Trim | 5 | SEC ↗ ×8 |
| 13 | D. E. Shaw & Co. ✦ | 961.33K | +582.0% | $317.80M | 0.3% | ▲ Add | 5 | SEC ↗ ×2 |
| 14 | Marshall Wace ✦ | 679.70K | Nieuw | $224.70M | 0.3% | New | 1 | SEC ↗ ×3 |
| 15 | Bridgewater Associates ✦ | 616.63K | +13.9% | $203.84M | 0.8% | ▲ Add | 5 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 550.71K | +56.0% | $182.05M | 0.3% | ▲ Add | 5 | SEC ↗ |
| 17 | Glenview Capital ✦ | 371.89K | -0.6% | $122.94M | 3.5% | ▼ Trim | 5 | SEC ↗ |
| 18 | Adage Capital Partners ✦ | 231.56K | +20.4% | $76.55M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 19 | Renaissance Technologies ✦ | 230.26K | +3143.1% | $76.12M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 20 | Millennium Management ✦ | 126.10K | +18609.2% | $41.69M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 21 | Greenlight Capital (DME Capital) ✦ | 93.75K | Nieuw | $30.99M | 1.3% | New | 1 | SEC ↗ ×2 |
| 22 | Gotham Asset Management ✦ | 66.52K | +4.4% | $21.99M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 23 | Wellington Management ✦ | 52.61K | +0.5% | $17.39M | 0.0% | ▲ Add | 5 | SEC ↗ ×3 |
| 24 | GAMCO Investors ✦ | 13.34K | -5.6% | $4.41M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 25 | Fisher Asset Management ✦ | 2.74K | +12.4% | $906,388 | 0.0% | ▲ Add | 5 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Marshall Wace | $224.70M | 0.3% |
| Greenlight Capital (DME… | $30.99M | 1.3% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1,635 houders, 229.05M aandelen, $59.07B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 617 aand · $175,259
Officer · 2.68K aand · $748,516
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie